Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Amarnath Challapalli
[18F]Fluciclatide PET as a Biomarker of Response to Combination Therapy of Pazopanib and Paclitaxel in Platinum-Resistant/Refractory Ovarian Cancer
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Pcn333 - Real-World Treatment Patterns of Patients With Advanced (Stage Ii-Iv) Ovarian Cancer Classified as Resistant or Refractory to Frontline Platinum-Based Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn384 - Health-Related Quality of Life in Patients With Advanced (Stage Ii-Iv) Ovarian Cancer Resistant or Refractory to Frontline Platinum-Based Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Multicenter Reproducibility of 18f-Fluciclatide PET Imaging in Subjects With Solid Tumors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro
Oncology Reports
Medicine
Cancer Research
Oncology
Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Phase I/Ii Study of GLIF Combination Chemotherapy for Taxane/Platinum-Refractory/Resistant Endometrial Cancer (GOGO-EM2)
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Pharmacokinetics of Paclitaxel and Metabolites in a Randomized Comparative Study in Platinum-Pretreated Ovarian Cancer Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
